Marie Brenden, ARNP-BC

Brett Gourley, MD, located in Spokane, WA, specializes in orthopedics and sports medicine, offering a comprehensive range of surgical and non-surgical treatment options for patients dealing with injuries and chronic conditions. Their dedicated team promotes a partner approach to care, aiming to facilitate a swift return to normal activities for individuals experiencing pain related to the back, neck, joints, and more. With locations throughout Washington State, Brett Gourley, MD, combines expertise with a patient-centered philosophy, providing personalized assessments and tailored treatment plans. The practice addresses a variety of orthopedic and sports medicine concerns, helping individuals overcome injuries, arthritis, and other joint health issues. Generated from the website

Dr. Swofford attended Washington State University, graduating with a Bachelor of Science in Zoology degree. He went on to attend medical school at A.T. Still University College of Osteopathic Medicine. He completed an internal medicine residency at the University of Arizona and subspeciality training in hematology and oncology at the University of Kentucky. Growing up in a rural farming community in Central Washington with a family of physicians, Dr. Swofford was introduced to the patient-physician relationship at a young age which ultimately inspired his passion for medicine and led him to pursue a career in Oncology, with a special interest in malignant and benign Hematology.

Dr. Molina is a graduate of Stanford University and received his medical degree from Baylor College of Medicine in Houston, Texas. He completed an Internal Medicine residency at the University of Texas in San Antonio and conducted his fellowship in Hematology–Oncology at the Fred Hutchinson Cancer Research Center/University of Washington in Seattle. In addition to traditional medical oncology therapy options, such as chemotherapy, Dr. Molina utilizes new cutting-edge treatment approaches like immune and targeted therapies, which look at cancers at the molecular level, allowing him to focus on treating these genetic mutations with more effectiveness and precision, with fewer side effects than traditional medical oncology treatments.